Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 15.02.2022
Defence Therapeutics Inc.
Einzigartig positioniert mit vielseitigem ACCUM(TM); Enormes
Aufwärtspotenzial; Die nächste Generation der Krebsbehandlung
- Proprietäre Plattformtechnologie mit nachweislich verbesserter
intrazellulärer Verabreichung. Fördert die Bereitstellung des
Zielprodukts ohne unspezifischen Protein-/Antigenabbau oder
[ … ]
Mon, 14.02.2022
Defence Therapeutics Inc.
Upcoming Investor Event:
Defence Therapeutics to present at digital International Investment Forum
(IIF)
On February 17, the IIF International Investment Forum will take place. At
this forum, Defence Therapeutics Inc. will also present its business model
and current business development.
Presentation slot:
Defence Therapeutics Inc.
08.00 am [ … ]
Sat, 12.02.2022
Cogia AG
Upcoming Investor Event:
Cogia to present at digital International Investment Forum (IIF)
On February 17, the IIF International Investment Forum will take place. At
this forum, Cogia AG will also present its business model and current
business development.
Presentation slot:
Cogia AG (ISIN: DE000A3H2226)
10.30 am EST (New York, Toronto time) [ … ]
Fri, 11.02.2022
Saturn Oil & Gas Inc.
Upcoming Investor Event:
Saturn Oil + Gas to present at digital International Investment Forum (IIF)
On February 17, the IIF International Investment Forum will take place. At
this forum, Saturn Oil + Gas will also present its business model and
current business development.
Presentation slot:
Saturn Oil + Gas Inc. (ISIN: CA80412L8832)
11.15 [ … ]
Thu, 10.02.2022
Advanced Blockchain AG
Advanced Blockchain AG is a venture builder and investor in the blockchain
ecosystem equipped with a comprehensive team of researchers, developers,
auditors, economists, and mathematicians dedicated to engineering the
future of Web 3.0.
GBC AG: Hello Mr. Geike, can you give me a quick rundown of your company,
your business model, and your strate [ … ]
Thu, 10.02.2022
Cardiol Therapeutics Inc.
Upcoming Investor Event:
Cardiol Therapeutics to present at digital International Investment Forum
(IIF)
On February 17, the IIF International Investment Forum will take place. At
this forum, Cardiol Therapeutics will also present its business model and
current business development.
Presentation slot:
Cardiol Therapeutics Inc. (ISIN: CA14161Y2 [ … ]
Thu, 10.02.2022
Defence Therapeutics Inc.
Uniquely Positioned with versatile ACCUM(TM); Enormous upside potential;
Next generation of cancer treatment
- Proprietary platform technology with proven enhanced intracellular
delivery. Promotes delivery of target product without non-specific
protein/antigen degradation or interference.
- Strong versatility of the Accum(TM) platf [ … ]
Wed, 09.02.2022
MagForce AG
In the past fiscal year 2021, MagForce AG made progress in both business
segments. Of particular note here is the approval granted by the FDA for
the start of Stage 2b for the treatment of prostate cancer patients. This
means that the pivotal study could be concluded as early as summer 2022. In
parallel, the treatment capacities for the indication [ … ]
Wed, 02.02.2022
Saturn Oil & Gas Inc.
Oxbow facilities
We had the chance to visit the newly acquired Oxbow Asset in September
2021. The site visit included a complete tour and presentation of new
management as well as a trip to production assets, pads, facilities and an
introduction to many employees and contractual companies. The assets
visited were located in a fairly concentrated [ … ]
Wed, 02.02.2022
Cogia AG
Preliminary results significantly above forecast, price target confirmed
On January 21, 2022, Cogia AG published its preliminary figures for the
2021 financial year and the figures presented exceed the GBC analysts'
forecasts. A total output of EUR 1.7 million was achieved in the group,
which corresponds to almost a threefold increase (previous [ … ]
